Seeking Alpha This is an immunomodulator , based on IL-2 and its receptors, which is ideally suited for using combination with cancer agents, including the newest, most exciting cancer agents like the checkpoint inhibitors. And we'll tell you more about that. So, the ... and more »
pharmabiz.com ... characteristic of the anti-retroviral therapies, the identification of a potential ' immunomodulator ' to control HIV-AIDS is of paramount importance,” said Dr Udaykumar Ranga, professor, Molecular Virology Laboratory of the Molecular Biology Unit ...
NASDAQ Along with this, the CHMP also issued a positive opinion on new active substance designation or NAS for Aubagio or teriflunomide, an immunomodulator with anti-i...
PharmaTimes ... use for the treatment of severely active Crohn's disease in paediatric patients aged six to 17 years of age, but only in those who failed to respond or are intolerant to conventional therapy, including nutrition therapy, corticosteroids and ...
